Achalasia Combined with Esophageal Cancer Treated by Concurrent Chemoradiation Therapy
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Achalasia is a rare neurological deficit of the esophagus that produces an impaired relaxation of the lower esophageal sphincter and decreased motility of the esophageal body. Achalasia is generally accepted to be a pre-malignant disorder, since, particularly in the mega-esophagus, chronic irritation by foods and bacterial overgrowth may contribute to the development of dysplasia and carcinoma. We present a case of a 51-year-old man with achalasia combined with esophageal cancer who has had dysphagia symptoms for more than 20 years. Since there was a clinically high possibility of supraclavicular lymph node metastasis, concurrent chemoradiation therapy was scheduled. After the third cycle of chemoradiation therapy, transthoracic esophageolymphadenectomy was performed. Histopathological examination of the main esophagus specimen revealed no residual carcinoma. And the entire regional lymph node areas were free of carcinoma except for one azygos metastatic lymph node. In summary, achalasia is a predisposing factor for esophageal squamous cell carcinoma. Although surveillance endoscopy in achalasia patients is still controversial, periodic screening for cancer development in long-standing achalasia patients might be advisable.
Abstract
Achalasia is a rare neurological deficit of the esophagus that produces an impaired relaxation of the lower esophageal sphincter and decreased motility of the esophageal body. Achalasia is generally accepted to be a pre-malignant disorder, since, particularly in the mega-esophagus, chronic irritation by foods and bacterial overgrowth may contribute to the development of dysplasia and carcinoma. We present a case of a 51-year-old man with achalasia combined with esophageal cancer who has had dysphagia symptoms for more than 20 years. Since there was a clinically high possibility of supraclavicular lymph node metastasis, concurrent chemoradiation therapy was scheduled. After the third cycle of chemoradiation therapy, transthoracic esophageolymphadenectomy was performed. Histopathological examination of the main esophagus specimen revealed no residual carcinoma. And the entire regional lymph node areas were free of carcinoma except for one azygos metastatic lymph node. In summary, achalasia is a predisposing factor for esophageal squamous cell carcinoma. Although surveillance endoscopy in achalasia patients is still controversial, periodic screening for cancer development in long-standing achalasia patients might be advisable.
참고문헌 (20)
- Fagge CH, "A case of simple stenosis of the oesophagus, followed by epithelioma", Guy's Hosp Rep, 17, pp.413~ (1872)
- Ellis FH Jr, "Esophageal achalasia and adenocarcinoma in Barrett's esophagus: a report of two cases and a review of the literature", Dis Esophagus, 10, pp.55~60 (1997)
- Brücher BL, "Achalasia and esophageal cancer: incidence, prevalence, and prognosis", World J Surg, 25, pp.745~749 (2001)
- Mayberry JF, "Epidemiology and demographics of achalasia", Gastrointest Endosc Clin N Am, 11, pp.235~248 (2001)
- Meijssen MA, "Achalasia complicated by oesophageal squamous cell carcinoma: a prospective study in 195 patients", Gut, 33, pp.155~158 (1992)
- Zendehdel K, "Risk of esophageal adenocarcinoma in achalasia patients, a retrospective cohort study in Sweden", Am J Gastroenterol (2007)
- Carter R, "Achalasia and esophageal carcinoma. in: Studies in early diagnosis for improved surgical management", Am J Surg, 130, pp.114~120 (1975)
- Goldblum JR, "Achalasia. in: A morphologic study of 42 resected specimens", Am J Surg Pathol, 18, pp.327~337 (1994)
- Pajecki D, "Megaesophagus microbiota: a qualitative and quantitative analysis", J Gastrointest Surg, 6, pp.723~729 (2002)
- Guo JP, "Barrett's esophagus and achalasia", J Clin Gastroenterol, 34, pp.439~443 (2002)
- Scholten P, "Barrett’s esophagus after pneumo-dilatation for achalasia", Gastroenterology, 126(2), pp.A635~ (2004)
- Sandler RS, "The risk of esophageal cancer in patients with achalasia. in: A population-based study", JAMA, 274, pp.1359~1362 (1995)
- Kelsen DP, "Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer", N Engl J Med, 339, pp.1979~1984 (1998)
- Leichman L, "Combined preoperative chemotherapy and radiation therapy for cancer of the esophagus: the Wayne State University, Southwest Oncology group and Radiation Therapy Oncology Group experience", Semin Oncol, 11, pp.178~185 (1984)
- al-Sarraf M, "Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study", J Clin Oncol, 15, pp.277~284 (1997)
- Cooper JS, "Chemoradiotherapy of locally advanced esophageal cancer: long-term follow- up of a prospective randomized trial (RTOG 85-01). in: Radiation Therapy Oncology Group", JAMA, 281, pp.1623~1627 (1999)
- Herskovic A, "Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus", N Engl J Med, 326, pp.1593~1598 (1992)
- Hayashi K, "Phase II evaluation of protracted infusion of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407)", Jpn J Clin Oncol, 31, pp.419~423 (2001)
- Bleiberg H, "Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer", Eur J Cancer, 33, pp.1216~1220 (1997)
- Holloway RH, "Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia", Gastroenterology, 90, pp.924~929 (1986)